Cutera, Inc.
Medical Devices & Tech
3240 Bayshore Blvd.
Brisbane, CA 94005 USA
phone: (415) 657-5500
fax: 415-330-2444
Symbol CUTR
Exchange Nasdaq
Founded 1998
Employees 195
www.cutera.com
Research Sector Medical Devices & Tech
Summary Description
Laser based products for aesthetic treatments.
Management
Kevin P. Connors, President and Chief Executive Officer; Ronald J. Santilli, Chief Financial Officer and Vice President of Finance and Administration; David A. Gollnick, Vice President of Research and Development; John Connors, Vice President North American Sales
Ownership
Financials Mkt Cap :108


* numbers in thousands

Recent Results
For the three months ended September 2006, revenue increased by $6.1 million, or 32%, to $25.1 million, compared to the third quarter of 2005.
 
Keywords
Aesthetics, plastic surgery, skin care

Comment | Printable Version | Nov. 01, 2008
If you work for Cutera, Inc. and want to update this profile, click here

Description
Cutera develops, manufactures and markets various products for use in laser and other light-based aesthetic applications.
Products / Services
The company's products are used for hair removal and reduction, for the treatment of vascular lesions, including leg and facial veins, and for skin rejuventation, including treatment of wrinkles and benign pigmented lesions. Cutera's product platforms include CoolGlide, Xeo and Solera. The company's Titan solutions, available on all three platforms, are used for dermal heating. The new Titan V and Titan XL offerings, launched in February 2006, give physicians an unobstructed view of the skin's surface, allowing for faster treatments and improved ability to treat sensitive areas, such as around the eyes and nose.
Technology / Differentiation
Cutera's CoolGlide, Xeo and Solera product platforms are upgradeable and have a broad range of applications. Customers are able to select the system that best fits their practice at the time of purchase and then cost-effectively add applications as their practice grows.
Market / Customers
Cutera's products are used by dermatologists, plastic surgeons, gynecologists, and primary care physicians. The worldwide market for laser and other light-based aesthetics systems is estimated at about $800 million annually. Cutera has a direct sales presence in the United States, Australia, Canada, France, Germany, Japan, Spain, Switzerland and the United Kingdom. The company has a distributor relationship in the U.S. with PSS World Medical.
Competitors / Substitutes / Alternatives
Candela Corp., Lumenis, Laserscope, Syneron, Palomar Medical Technologies, Novalis Medical, Asclepion Laser Technologies, Cynosure, Opus Medical
Strategy
Cutera is focused on continuous introduction of new aesthetic products and applications, marketing to physicians outside the core dermatologist and plastic surgeon specialties (including the medi-spa market) and expansion of its marketing efforts and direct sales force increase market penetration.
Funding
Status
Awaiting Content Update


2008-11-21-1175